Dahella, Simarjot S.
Briggs, James S. http://orcid.org/0000-0003-1559-4879
Coombes, Paul
Farajidavar, Nazli
Meredith, Paul
Bonnici, Timothy
Darbyshire, Julie L.
Watkinson, Peter J.
Funding for this research was provided by:
Wellcome Trust (HICF-R9-524; WT-103703/Z/14/Z)
Article History
Received: 5 March 2019
Accepted: 2 July 2020
First Online: 16 July 2020
Ethics approval and consent to participate
: REC (Research Ethics Committee) approval 16/SC/0264 and CAG (Confidentiality Advisory Group) approval 16/SC/0066.
: Not applicable.
: PW co-developed the System for Electronic Notification and Documentation (SEND), for which Sensyne Health has purchased a sole licence. The company has a research agreement with the University of Oxford and royalty agreements with Oxford University Hospitals NHS Trust and the University of Oxford. PW was the Chief Medical Officer for Sensyne Health and holds shares in the company. His department has received funding from Sensyne Health. PW and TB receive royalties on sales of SEND from Sensyne Health. The other authors declare that they have no competing interests.